NACI issues Canadian guidance for use of RSV vaccines in older adultsThe risk of severe respiratory syncytial virus (RSV) disease increases with age and with certain medical conditions. Meet the centenarians: Canada's oldest age group is also its fastest-growingStatistics Canada data show the country’s population of people aged at least 100 more than tripled between 2000 and 2023, up from 3,393 to 11,705. Updates in the management of behavioural and psychological symptoms of dementia New guidelines aim to equip healthcare professionals to better treat and support patients and their caregivers. Understanding the interplay of menopausal hormone therapy and dementia For women under the age of 65 years, especially those under the age of 55 years, there appears to be no increased risk of dementia with MHT. Does melatonin have any effect on the development or progression of AMD? Study examines the association between melatonin supplementation and the risk of the development or progression of age-related macular degeneration. Does long-term use of low-dose ASA affect the incidence or progression of AMD? Study examines whether low-dose daily acetylsalicylic acid (ASA) prevents the development or progression of age-related macular degeneration (AMD). Cannabis legalization coincided with uptick in ER visits from seniors: study A dive into the data suggests edibles may be to blame. How common is inappropriate diagnosis of community-acquired pneumonia? A new study examined how often adults are misdiagnosed with CAP and explored some of the more frequent consequences. New antibiotics underused in antibiotic-resistant infections: U.S. study A new study published in the Annals of Internal Medicine suggests that healthcare providers aren’t prescribing these new options as much as they should. Antipsychotics associated with a wide range of adverse outcomes in dementia Risks of a broad range of adverse outcomes need to be considered before prescribing antipsychotic drugs for people with dementia. First Previous 1 2 3 4 5 Next Last